£19.99 – £44.99Price range: £19.99 through £44.99
For research use only — Not for human or animal use
MT2 10mg, also known as Melanotan II, is a synthetic peptide analogue of alpha melanocyte-stimulating hormone (α-MSH). It is studied for its interaction with melanocortin receptors linked to pigmentation signalling and peptide-receptor activity.
Originally developed for melanocortin research, Melanotan II has become widely discussed in studies involving melanin synthesis, receptor-binding behaviour, and peptide signalling models. Researchers are particularly interested in how synthetic melanocortin analogues behave compared to naturally occurring melanocyte-stimulating hormone activity within biological systems.
Melanotan II is a synthetic peptide designed to mimic certain actions associated with α-MSH signalling. It has a strong binding affinity for melanocortin receptors, particularly MC1R, which is linked to melanin production and pigmentation response.
Because of this receptor interaction profile, MT2 is commonly used in:
Researchers also use Melanotan II in studies comparing synthetic peptide behaviour against endogenous melanocyte-stimulating hormone pathways. Its molecular structure and receptor activity have made it a major focus in melanocortin receptor research involving cellular signalling and peptide interaction analysis.
Research involving Melanotan II focuses on how melanocortin receptor activation influences peptide signalling, pigmentation response, and melanin-related biological activity.
Studies in this area often examine:
MT2 has also been included in assay development models where researchers analyse receptor activation patterns and signalling behaviour over longer observation periods. In addition to pigmentation-related research, scientists continue studying how melanocortin receptors influence broader biological signalling processes connected to peptide communication within cells.
As with similar receptor-targeting compounds, adverse effects and receptor-response variability continue to be evaluated through ongoing laboratory observation.These findings remain limited to research settings and are not established for clinical use.
Research involving Melanotan II has explored several areas linked to melanocortin receptor activity and peptide signalling behaviour.
Studies have looked at areas such as:
Researchers are particularly interested in how synthetic melanocyte-stimulating hormone analogues influence receptor-binding behaviour and peptide signalling within cellular systems. Ongoing studies continue to evaluate receptor response patterns, signalling behaviour, and adverse effects observed during longer-term peptide analysis.
Our MT2 10mg vial is supplied as a dry peptide powder intended for laboratory handling and controlled preparation protocols. Reconstitution should be carried out under standard laboratory conditions using validated preparation procedures that are suitable for the assay requirements.
Standard handling practices include:
Following structured laboratory protocols helps support peptide stability and reliable analytical observation.
Disclaimer: This product is sold strictly for research purposes only. Not for human consumption.
Discount Applied Successfully!
Your savings have been added to the cart.